High-salt diet enhances mouse aortic relaxation through adenosine A 2A receptor via CYP epoxygenases

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 296, Issue 3, 2009, Pages

  Nayeem, Mohammed A ^a   Ponnoth, Dovenia S ^a   Boegehold, Matthew A ^a   Zeldin, Darryl C ^b   Falck, John R ^c   Mustafa, S Jamal ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Vasoconstriction; Vasodilation

Indexed keywords

14,15 EPOXY 5,8,11 ICOSATRIENOIC ACID; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; CYTOCHROME P450; CYTOCHROME P450 2C; CYTOCHROME P450 2C29; CYTOCHROME P450 4A; CYTOCHROME P450 INHIBITOR; DIBROMODODECENYLMETHYLSULFIMIDE; ENZYME INHIBITOR; HET 0016; HEXAPROPYMATE; MESYLIC ACID DERIVATIVE; N(G) NITROARGININE METHYL ESTER; SODIUM CHLORIDE; UNCLASSIFIED DRUG; 20 HYDROXY 5,8,11,14 EICOSATETRAENOIC ACID; 20-HYDROXY-5,8,11,14-EICOSATETRAENOIC ACID; ACETYLCHOLINE; ADENOSINE; ALKANE 1 MONOOXYGENASE; ANTIHYPERTENSIVE AGENT; ARACHIDONATE EPOXYGENASE; DRUG DERIVATIVE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROXYICOSATETRAENOIC ACID; PHENETHYLAMINE DERIVATIVE; VASODILATOR AGENT;

ANIMAL TISSUE; AORTA; ARTERY CONSTRICTION; ARTERY DILATATION; ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; KIDNEY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALT INTAKE; UPREGULATION; ABDOMINAL AORTA; ANIMAL; C57BL MOUSE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; MUSCLE RELAXATION; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; SODIUM INTAKE; THORACIC AORTA; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ACETYLCHOLINE; ADENOSINE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ALKANE 1-MONOOXYGENASE; ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA, ABDOMINAL; AORTA, THORACIC; BLOTTING, WESTERN; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INHIBITORS; HYDROXYEICOSATETRAENOIC ACIDS; MICE; MICE, INBRED C57BL; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE TYPE III; PHENETHYLAMINES; RECEPTOR, ADENOSINE A2A; SODIUM, DIETARY; VASODILATOR AGENTS;

EID: 64149129571     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.90798.2008     Document Type: Article

References (52)

1. Abebe W, Makujina SR, Mustafa SJ. Adenosine receptor-mediated relaxation of porcine coronary artery in presence and absence of endothelium. Am J Physiol Heart Circ Physiol 266: H2018-H2025, 1994. (Pubitemid 24172143)
2. 2A adenosine receptor mediates coronary vasodilation. J Pharmacol Exp Ther 284: 1066-1073, 1998.
3. Biaggioni I. Contrasting excitatory and inhibitory effects of adenosine in blood pressure regulation. Hypertension 20: 457-465, 1992.
4. Blanton A, Nsaif R, Hercule H, Oyekan A. Nitric oxide/cytochrome P450 interactions in cyclosporin A-induced effects in the rat. J Hypertens 24: 1865-1872, 2006. (Pubitemid 44253249)
5. Capdevila JH, Wei S, Yan J, Karara A, Jacobson HR, Falck JR, Guengerich FP, DuBois RN. Cytochrome P-450 arachidonic acid epoxygenase. Regulatory control of the renal epoxygenase by dietary salt loading. J Biol Chem 267: 21720-21726, 1992.
6. Carroll MA, Doumad AB, Li J, Cheng MK, Falck JR, McGiff JC. Adenosine2A receptor vasodilation of rat preglomerular microvessels is mediated by EETs that activate the cAMP/PKA pathway. Am J Physiol Renal Physiol 291: F155-F161, 2006. (Pubitemid 43945946)
7. Cheng MK, Doumad AB, Jiang H, Falck JR, McGiff JC, Carroll MA. Epoxyeicosatrienoic acids mediate adenosine-induced vasodilation in rat preglomerular microvessels (PGMV) via A2A receptors. Br J Pharmacol 141: 441-448, 2004. (Pubitemid 38297007)
8. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, Busse R. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401: 493-497, 1999. (Pubitemid 129515789)
9. Fleming I. Cytochrome p450 and vascular homeostasis. Circ Res 89: 753-762, 2001. (Pubitemid 34633845)
10. Frisbee JC, Falck JR, Lombard JH. Contribution of cytochrome P-450 ω-hydroxylase to altered arteriolar reactivity with high-salt diet and hypertension. Am J Physiol Heart Circ Physiol 278: H1517-H1526, 2000.
11. Frisbee JC, Lombard JH. Parenchymal tissue cytochrome P450 4A enzymes contribute to oxygen-induced alterations in skeletal muscle arteriolar tone. Microvasc Res 63: 340-343, 2002.
12. Fulton D, McGiff JC, Quilley J. Pharmacological evaluation of an epoxide as the putative hyperpolarizing factor mediating the nitric oxide-independent vasodilator effect of bradykinin in the rat heart. J Pharmacol Exp Ther 287: 497-503, 1998. (Pubitemid 29133645)
13. Granberg AL, Brunstrom B, Brandt I. Cytochrome P450-dependent binding of 7,12-dimethylbenz[a]anthracene (DMBA) and benzo[a]pyrene (B[a]P) in murine heart, lung, and liver endothelial cells. Arch Toxicol 74: 593-601, 2000. (Pubitemid 32010388)
14. Hao CM, Breyer MD. Physiologic and pathophysiologic roles of lipid mediators in the kidney. Kidney Int 71: 1105-1115, 2007.
15. Hein TW, Belardinelli L, Kuo L. Adenosine A2A receptors mediate coronary microvascular dilation to adenosine: role of nitric oxide and ATP-sensitive potassium channels. J Pharmacol Exp Ther 291: 655-664, 1999. (Pubitemid 29503538)
16. Ito O, Roman RJ. Regulation of P-450 4A activity in the glomerulus of the rat. Am J Physiol Regul Integr Comp Physiol 276: R1749-R1757, 1999. (Pubitemid 29323541)
17. Jackson EK, Zhu C, Tofovic SP. Expression of adenosine receptors in the preglomerular microcirculation. Am J Physiol Renal Physiol 283: F41-F51, 2002. (Pubitemid 34680470)
18. Kerzee JK, Ramos KS. Constitutive and inducible expression of Cyp1a1 and Cyp1b1 in vascular smooth muscle cells: role of the Ahr bHLH/PAS transcription factor. Circ Res 89: 573-582, 2001.
19. +-ATPase are age dependent. Am J Physiol Renal Physiol 278: F823-F829, 2000.
20. Liclican EL, McGiff JC, Pedraza PL, Ferreri NR, Falck JR, Carroll MA. Exaggerated response to adenosine in kidneys from high salt-fed rats: role of epoxyeicosatrienoic acids. Am J Physiol Renal Physiol 289: F386-F392, 2005.
21. Luo G, Zeldin DC, Blaisdell JA, Hodgson E, Goldstein JA. Cloning and expression of murine CYP2Cs and their ability to metabolize arachidonic acid. Arch Biochem Biophys 357: 45-57, 1998. (Pubitemid 28402584)
22. + channels in A6 distal nephron cells. Am J Physiol Renal Fluid Electrolyte Physiol 270: F798-F805, 1996.
23. Makita K, Takahashi K, Karara A, Jacobson HR, Falck JR, Capdevila JH. Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet. J Clin Invest 94: 2414-2420, 1994. (Pubitemid 24379616)
24. McCoy DE, Bhattacharya S, Olson BA, Levier DG, Arend LJ, Spielman WS. The renal adenosine system: structure, function, and regulation. Semin Nephrol 13: 31-40, 1993.
25. Michaelis UR, Falck JR, Schmidt R, Busse R, Fleming I. Cytochrome P4502C9-derived epoxyeicosatrienoic acids induce the expression of cyclooxygenase- 2 in endothelial cells. Arterioscler Thromb Vasc Biol 25: 321-326, 2005. (Pubitemid 40189152)
26. Michaelis UR, Fleming I. From endothelium-derived hyperpolarizing factor (EDHF) to angiogenesis: Epoxyeicosatrienoic acids (EETs) and cell signaling. Pharmacol Ther 111: 584-595, 2006. (Pubitemid 44160519)
27. Miller WL, Thomas RA, Berne RM, Rubio R. Adenosine production in the ischemic kidney. Circ Res 43: 390-397, 1978. (Pubitemid 9019764)
28. 2B receptors. Am J Physiol Heart Circ Physiol 282: H437-H444, 2002.
29. ATP channels. Naunyn Schmiedebergs Arch Pharmacol 367: 219-226, 2003.
30. Nayeem MA, Mustafa SJ. Mechanisms of delayed preconditioning with A1 adenosine receptor activation in porcine coronary smooth muscle cells. Pol J Pharmacol 54: 443-453, 2002.
31. Nayeem MA, Mustafa SJ. Protein kinase C isoforms and A1 adenosine receptors in porcine coronary smooth muscle cells. Vascul Pharmacol 39: 47-54, 2002.
32. Nayeem MA, Poloyac SM, Falck JR, Zeldin DC, Ledent C, Ponnoth DS, Ansari HR, Mustafa SJ. Role of CYP-epoxygenases in A2A adenosine receptor-mediated relaxation using A2AAR-null and wild-type mice. Am J Physiol Heart Circ Physiol 295: H2068-H2078, 2008.
33. Nayeem MA, Boegehold Mustafa MA, SJ. Adenosine A2A receptor mediated aortic relaxation in mice fed high salt: role of CYP epoxygenase. FASEB J 21: A899-A900, 2007.
34. 2A adenosine receptor-KO mouse aorta: role of CYP2C9 and CYP 4A. FASEB J 21: A1381-A1381, 2007.
35. Node K, Huo Y, Ruan X, Yang B, Spiecker M, Ley K, Zeldin DC, Liao JK. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285: 1276-1279, 1999. (Pubitemid 29398616)
36. +-ATPase. J Clin Invest 99: 1224-1230, 1997.
37. Nurkiewicz TR, Boegehold MA. High salt intake reduces endothelium-dependent dilation of mouse arterioles via superoxide anion generated from nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 292: R1550-R1556, 2007.
38. 2A adenosine receptor: a novel therapeutic target in renal disease. Am J Physiol Renal Physiol 282: F10-F18, 2002.
39. Pawlowska D, Granger JP, Knox FG. Effects of adenosine infusion into renal interstitium on renal hemodynamics. Am J Physiol Renal Fluid Electrolyte Physiol 252: F678-F682, 1987.
40. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 50: 413-492, 1998. (Pubitemid 28477681)
41. Siragy HM, Linden J. Sodium intake markedly alters renal interstitial fluid adenosine. Hypertension 27: 404-407, 1996. (Pubitemid 26083056)
42. Spielman WS, Arend LJ. Adenosine receptors and signaling in the kidney. Hypertension 17: 117-130, 1991.
43. Talukder MA, Morrison RR, Mustafa SJ. Comparison of the vascular effects of adenosine in isolated mouse heart and aorta. Am J Physiol Heart Circ Physiol 282: H49-H57, 2002.
44. Taubes G. The (political) science of salt. Science 281: 898-901, 903-1897, 1998.
45. 1 adenosine receptors in regulation of vascular tone. Am J Physiol Heart Circ Physiol 288: H1411-H1416, 2005.
46. 1 adenosine receptor in the regulation of coronary flow. Am J Physiol Heart Circ Physiol 291: H467-H472, 2006.
47. 1 adenosine receptor-knockout mice. Am J Physiol Heart Circ Physiol 290: H1713-H1720, 2006.
48. Thum T, Borlak J. Gene expression in distinct regions of the heart. Lancet 355: 979-983, 2000. (Pubitemid 30148264)
49. Wu S, Chen W, Murphy E, Gabel S, Tomer KB, Foley J, Steenbergen C, Falck JR, Moomaw CR, Zeldin DC. Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes. J Biol Chem 272: 12551-12559, 1997. (Pubitemid 27203348)
50. Zhao X, Pollock DM, Inscho EW, Zeldin DC, Imig JD. Decreased renal cytochrome P450 2C enzymes and impaired vasodilation are associated with angiotensin salt-sensitive hypertension. Hypertension 41: 709-714, 2003. (Pubitemid 36314579)
51. Zhao X, Pollock DM, Zeldin DC, Imig JD. Salt-sensitive hypertension after exposure to angiotensin is associated with inability to upregulate renal epoxygenases. Hypertension 42: 775-780, 2003. (Pubitemid 37237324)
52. Zou AP, Wu F, Li PL, Cowley AW Jr. Effect of chronic salt loading on adenosine metabolism and receptor expression in renal cortex and medulla in rats. Hypertension 33: 511-516, 1999. (Pubitemid 29065712)